Stonehage Fleming Financial Services Holdings Ltd Trims Stock Holdings in Stryker Corporation $SYK

Stonehage Fleming Financial Services Holdings Ltd lowered its stake in Stryker Corporation (NYSE:SYK) by 3.3% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 434,666 shares of the medical technology company’s stock after selling 14,771 shares during the quarter. Stryker comprises about 4.7% of Stonehage Fleming Financial Services Holdings Ltd’s portfolio, making the stock its 12th biggest holding. Stonehage Fleming Financial Services Holdings Ltd’s holdings in Stryker were worth $152,772,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors have also made changes to their positions in the stock. Brighton Jones LLC increased its holdings in Stryker by 15.4% in the 4th quarter. Brighton Jones LLC now owns 4,564 shares of the medical technology company’s stock valued at $1,643,000 after purchasing an additional 609 shares during the last quarter. Schnieders Capital Management LLC. acquired a new position in Stryker during the second quarter worth $205,000. Maia Wealth LLC acquired a new position in Stryker during the second quarter worth $531,000. Fortress Financial Solutions LLC boosted its position in shares of Stryker by 3.8% during the second quarter. Fortress Financial Solutions LLC now owns 895 shares of the medical technology company’s stock worth $354,000 after buying an additional 33 shares during the period. Finally, Vinva Investment Management Ltd grew its stake in shares of Stryker by 15.3% in the second quarter. Vinva Investment Management Ltd now owns 20,871 shares of the medical technology company’s stock valued at $8,214,000 after buying an additional 2,773 shares in the last quarter. 77.09% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling at Stryker

In related news, Director Ronda E. Stryker sold 250,000 shares of the firm’s stock in a transaction that occurred on Wednesday, February 4th. The shares were sold at an average price of $362.92, for a total value of $90,730,000.00. Following the sale, the director owned 2,457,331 shares of the company’s stock, valued at $891,814,566.52. This trade represents a 9.23% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 5.90% of the company’s stock.

Analyst Upgrades and Downgrades

Several equities research analysts recently issued reports on SYK shares. Needham & Company LLC boosted their price objective on Stryker from $448.00 to $454.00 and gave the company a “buy” rating in a report on Friday, January 30th. Citigroup reaffirmed a “market outperform” rating on shares of Stryker in a research report on Friday, January 30th. Piper Sandler reiterated an “overweight” rating on shares of Stryker in a research note on Tuesday, January 27th. BTIG Research increased their price target on shares of Stryker from $410.00 to $412.00 and gave the stock a “buy” rating in a research report on Friday, January 30th. Finally, Jefferies Financial Group reissued a “buy” rating and issued a $465.00 price objective on shares of Stryker in a research note on Wednesday, March 4th. Fourteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. According to MarketBeat.com, Stryker currently has a consensus rating of “Moderate Buy” and a consensus price target of $427.50.

Stryker Trading Up 1.5%

NYSE:SYK opened at $332.58 on Friday. The firm has a market cap of $127.37 billion, a PE ratio of 39.59, a price-to-earnings-growth ratio of 1.92 and a beta of 0.85. The stock has a fifty day moving average price of $360.91 and a 200 day moving average price of $364.35. Stryker Corporation has a 12-month low of $324.93 and a 12-month high of $404.87. The company has a current ratio of 1.89, a quick ratio of 1.21 and a debt-to-equity ratio of 0.66.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, January 29th. The medical technology company reported $4.47 earnings per share for the quarter, topping the consensus estimate of $4.40 by $0.07. The company had revenue of $7.17 billion for the quarter, compared to the consensus estimate of $7.12 billion. Stryker had a return on equity of 24.41% and a net margin of 12.92%.Stryker’s revenue was up 11.4% on a year-over-year basis. During the same quarter in the prior year, the business earned $4.01 EPS. Sell-side analysts anticipate that Stryker Corporation will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, April 30th. Investors of record on Tuesday, March 31st will be paid a dividend of $0.88 per share. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Tuesday, March 31st. Stryker’s dividend payout ratio is presently 41.90%.

Stryker Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.